Connection
Corey Hayes to Narcotic Antagonists
This is a "connection" page, showing publications Corey Hayes has written about Narcotic Antagonists.
|
|
Connection Strength |
|
|
|
|
|
1.277 |
|
|
|
-
Hayes CJ, Raciborski RA, Nowak M, Acharya M, Nunes EV, Winhusen TJ. Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type. Addiction. 2025 Jan; 120(1):138-151.
Score: 0.893
-
Hayes CJ, Martin BC, Hoggatt KJ, Cucciare MA, Hudson TJ, Gordon AJ. Average Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder. Subst Use Addctn J. 2024 Oct; 45(4):727-735.
Score: 0.222
-
Acharya M, Chopra D, Hayes CJ, Teeter B, Martin BC. Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users. Value Health. 2020 04; 23(4):451-460.
Score: 0.163